StockGuru Blog: NextGen Bioscience (NXGB) – Potential Candidates and Acquisition Pipeline
Wednesday, April 9th, 2008 NexGen’s proprietary anti-cancer candidates include Prostaganin (targeting prostate cancer) and Tetanolic (targeting breast cancer) which have,…